Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.24.1.1.u2
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2024
Jun. 30, 2023
Current assets:    
Cash and cash equivalents $ 5,302,000 $ 4,301,000
Restricted cash 914,000 3,025,000
Subscription receivable 14,104,000 204,000
Prepaid expenses and other current assets 862,000 664,000
Current assets held for sale 14,957,000 18,065,000
Total Current Assets 36,139,000 26,259,000
Restricted cash 215,000 253,000
Promissory note receivable and accrued interest 1,772,000 1,706,000
Net finance lease ROU assets 407,000 610,000
Operating lease right-of-use asset 2,472,000 2,722,000
Fixed assets, net of accumulated depreciation 3,726,000 4,219,000
Intangible assets, net of accumulated amortization 5,373,000 5,388,000
Security deposits 50,000 50,000
Total Assets 50,154,000 41,207,000
Current liabilities:    
Accounts payable 1,228,000 1,849,000
Accrued expenses 3,998,000 4,034,000
Finance lease obligations - current portion 292,000 272,000
Operating lease obligation - current portion 424,000 389,000
Equipment financing payable - current portion 173,000 160,000
Term promissory note - current portion 208,000  
Insurance premium financing payable 340,000  
Term note payable - net of deferred financing costs 12,655,000 12,937,000
Contract liabilities 175,000  
Current liabilities related to assets held for sale 1,933,000 1,941,000
Total Current Liabilities 21,426,000 21,582,000
Finance lease obligations - net of current portion 130,000 351,000
Operating lease obligation - net of current portion 2,801,000 3,125,000
Equipment financing payable - net of current portion 110,000 241,000
Term promissory note - net of current portion 824,000  
Accrued expenses - noncurrent   527,000
Total Liabilities 25,291,000 25,826,000
Stockholders' Equity    
Series 2022 Convertible Preferred Stock - $0.001 par value; 1,000,000 shares authorized at December 31, 2023 and June 30, 2023; 0 and 0 shares issued and outstanding as of December 31, 2023 and June 30, 2023, respectively
Common Stock - $0.001 par value; 275,000,000 shares authorized at December 31, 2023 and June 30, 2023; 3,243,725 and 1,015,505 shares issued and outstanding as of December 31, 2023 and June 30, 2023, respectively 9,000 1,000
Additional paid-in capital 330,923,000 304,320,000
Accumulated deficit (306,069,000) (288,940,000)
Total Stockholders' Equity 24,863,000 15,381,000
Total Liabilities and Stockholders' Equity $ 50,154,000 $ 41,207,000